Query No. 2 (ii) Treatment of investment in own shares for EPS calculation in the standalone financial statements. (iii) Treatment of ESOP Trust in the financial statements for tax audit Purposes.[1] A. Facts of the Case
The company records the charge (intrinsic value–grant price) in its own books. 2. The querist has drawn the attention of the Committee to paragraph 45 of the ‘Guidance Note on Accounting for Employee Share-based Payments’, (the Guidance Note’) issued by the Institute of Chartered Accountants of India (the ‘ICAI’), which reads as below:
3. The querist has also drawn the attention of the Committee to Clause 22A.1 of the Securities and Exchange Board of India (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999 (hereinafter referred to as ‘the SEBI Guidelines’), dealing with accounting for employee stock option scheme (‘ESOS’) and employee stock purchase scheme (‘ESPS’) through Trust route, which reads as below:
4. The querist has made an analysis evaluating whether the transactions of the ESOPT should be included in the standalone financial statements of the company. As per the querist, the following reasons suggest consolidation of ESOPT in the separate financial statements of the company:
5. The main issue arising from the above view is the manner of disclosure of the shares of the company held by ESOPT at the year end and the loan given by the company to ESOPT. As per the querist, as far as shares held by the Trust at the year end are concerned, these can be reflected in the standalone financial statements of the company. The face value of these shares should be shown as a deduction from share capital and the excess amount paid over and above the face value should be shown as deduction from securities premium with a detailed note explaining the facts. This is on the basis that to the extent own shares are purchased by the company from the market, the Shareholders' Funds stand reduced[2]. In the books of account, these shares will continue to remain recorded in a separate account and, only for disclosure purposes, they would be shown as deduction from share capital/securities premium. There will not be an accounting entry made in the ledger debiting ‘Share Capital/Securities Premium’ and crediting ‘Investment in Own shares’. This is because, such an entry may be construed as effecting a reduction of capital/utilisation of securities premium and, thus, giving rise to attendant legal issues. (Emphasis supplied by the querist.) 6. As per the querist, the ICAI’s Guidance Note also recommends the above method of presentation in a situation where the enterprise provides finance to the ESOP Trust for subscription of shares issued by it (i.e., the enterprise) at the beginning of the plan. In case the enterprise provides finance to the Trust for purchasing shares from the market, lCAl's Guidance Note requires loan given to the Trust as asset in the enterprise's balance sheet. However, the genesis of this seems to be in the fact that unlike SEBI Guidelines, ICAI’s Guidance Note treats the ESOP Trust as a separate entity. Accordingly, the activities of the trust are not reflected in standalone financial statements of the enterprise. Further, as per the Guidance Note, ESOP Trust is not consolidated. 7. However, the company’s management is of the view that since both the SEBI Guidelines and the ICAI’s Guidance Note require that as the Trust administers the plan on behalf of the company, the company will recognise any expense arising from the employee share-based payment plans as if the company itself is administering the plan. However, it should not incorporate any other balance of the ESOP in the standalone financial statements of the company. Thus, the loan from the company to ESOPT will not be eliminated and would appear in the standalone financial statements of the company. In view of paragraph 45 of the ICAI’s Guidance Note, the Trust should not be consolidated for the purpose of Consolidated Financial Statements as per Indian Generally Accepted Accounting Principles (GAAPs). 8. Another issue which arises is how to consider investment in own shares in the standalone financial statements of company A for the purpose of calculating basic and diluted earnings per share. The querist has drawn attention of the Committee to paragraph 46 of the ICAI’s Guidance Note on Accounting for Employee Share-based Payments, dealing with the issue of EPS, which reads as below:
As per the querist, the above seems to suggest that the shares purchased by the Trust from the market should be excluded in calculating weighted average number of outstanding shares for the purposes of basic EPS calculation. However, for purposes of diluted EPS computation, such shares would be considered as potential equity shares. 9. As per the querist, a note should be given in the notes to accounts, which should bring out the requirement of Clause 22A.1 of the SEBI Guidelines pointing out that pursuant to this requirement, the activities of the Trust have been deemed as those undertaken by the company and dealt with accordingly. 10. Considering the above analysis, another issue which requires deliberation is the accounting treatment to be followed in the financial statement prepared under Section 44 AB of the Income-tax Act, 1961 i.e., for the year ended 31st March. It is pertinent to note that these financial statements are prepared for a specific purpose for compliance with the Income-tax Act, 1961 and not for the purpose of compliance with any SEBI requirements. 11. The format of Form 3CB requires the tax auditor to state whether the financial statements of the company
12. The querist has drawn the attention of the Committee to the following extracts from the ‘Guidance Note on Tax Audit under section 44AB of the Income-tax Act, 1961’, issued by the Institute of Chartered Accountants of India:
13. A question arises as to whether, for the purpose of compliance with the provisions of the Income-tax Act, 1961, the company, being a listed company, should comply with the SEBI Guidelines (as adhered to for the purposes of preparation of annual accounts) or the ICAI’s Guidance Note while preparing its financials statements for the year ended 31st March. The querist has analysed this issue for the following two situations:
Companies covered under the provisions of MAT 14. The querist has quoted the following portion of MAT provisions[3] :
Companies not covered under the provisions of MAT 15. The next issue relates to the position where section 115JB is not applicable to a company. In this regard, the querist has made reference to paragraph 44 of the ‘Framework for the Preparation and Presentation of Financial Statements’, issued by the ICAI as per which "the benefits derived from information should exceed the cost of providing it". In the financial statements submitted under the Companies Act, 1956, certain information is disclosed to comply with the statutory requirements. As per the querist, such information may not have a bearing on the true and fair view of the financial statements prepared for tax purposes (Form 3CB). The stakeholders have access to the statutory financial statements. Further, as per the querist, the need of tax authorities seems to be met by the disclosures relevant for a true and fair view and, in this regard, the following portion of paragraph 10.7 of the Guidance Note on Tax Audit discussed in paragraph 12 above is relevant:
16. Accordingly, as per the querist, in the absence of any clear guidance, an assessee may elect to comply with the ICA1’s Guidance Note for the purpose of preparation of accounts for the year ended 31st March whilst complying with the SEBI Guidelines for the purpose of preparation of annual accounts. B. Query 17. The querist has sought the opinion of the Expert Advisory Committee on the following issues:
C. Points considered by the Committee 18. The Committee notes that the basic issues raised by the querist relate to (i) inclusion of the operations of the ESOP Trust (‘ESOPOT’) in the standalone financial statements of the company, (ii) treatment of investment by ESOPT in the shares of the company for calculating basic and diluted earnings per share (‘EPS’) in the standalone financial statements of the company, and (iii) treatment in the financial statements prepared for tax audit purposes. The Committee has considered only these issues and has not examined any other issue that may be contained in the Facts of the Case. The Committee also notes that the charge on account of ESOP is stated by the querist as ‘intrinsic value – grant price’ in paragraph 1 above. It seems that the charge is intrinsic value i.e., ‘market price – exercise price’ (market price, for this purpose, is as defined in the ‘SEBI Guidelines’ and exercise price being equal to grant price, which in the extant case is face value of the share). However, this does not affect the opinion of the Committee. Also, the querist has not stated whether the company has allotted shares to ESOPT in respect of all the stock options granted or in respect of expected number of vested options likely to be exercised by the employees. However, this does not affect the opinion of the Committee. Further, the Committee wishes to point out that its opinion is expressed purely from accounting point of view and not from any legal point of view, such as, interpreting the provisions of the Income-tax Act, 1961, i.e., expressing any view on computation of income for the purpose of the Income-tax Act, 1961 since as per Rule 2 of the Advisory Service Rules of the Committee, the Committee does not answer issues that involve only interpretation of enactments. 19. The Committee is of the view that, in case of listed companies, if there are certain differences between the ‘Guidance Note’ issued by the Institute of Chartered Accountants of India and the ‘SEBI Guidelines’ then to the extent the requirements of the SEBI Guidelines differ from the Guidance Note, the SEBI Guidelines will prevail. 20. The Committee notes Clause 22A.1 of the ‘SEBI Guidelines’ (also quoted by the querist in paragraph 3 above) which reads as below:
Thus, though ESOPT itself may prepare its own financial statements, for example, to meet regulatory requirements, the standalone financial statements of the company should portray the picture as if the company itself is administering the ESOP Scheme. The Committee is of the view that this has two results viz., (i) the company should recognise any expense arising from the employee share-based payment plans, and (ii) the operations of ESOPT are included in standalone financial statements of the company insofar as the ESOP is concerned. In such a situation, in the standalone financial statements of the company, ‘Loans to ESOPT’ will not appear at all. Accordingly, the following adjustments are required:
21. As regards the issue of calculation of earnings per share (‘EPS’) in the standalone financial statements of the company, the Committee notes that at present, AS 20, ‘Earnings Per Share’, notified under the Companies (Accounting Standards) Rules, 2006 (hereinafter referred to as ‘the Rules’) and the Guidance Note complement each other and, hence, both should be considered in a harmonious manner in addressing the issue on EPS calculation. The Committee notes that as per the Facts of the Case, the employees would be granted stock options which are directly linked to individual, team and company performance. The Committee is of the view that such performance-based employee stock options should be treated as contingently issuable equity shares under AS 20. Further, the Committee is of the view that the principles enunciated in AS 20 in respect of options and contingently issuable equity shares are equally applicable for shares allotted to ESOPT which, in turn, will be allotted in future to employees on exercise of their options. In reaching this conclusion, the Committee notes the expression ‘shares or stock options issued to an ESOP Trust’ occurring in paragraph 46 of the Guidance Note, reproduced by the querist in paragraph 8 above. [Emphasis added by the Committee]. In the light of the above discussion, the Committee is of the following views:
The Committee also notes that paragraph 46 of the Guidance Note quoted by the querist in paragraph 8 above deals, inter alia, with the situation where shares or options are ‘issued’ to the ESOPT and not with the situation where shares are purchased by ESOPT from the market. Consequently, the Committee does not agree with the querist’s statement in paragraph 8 above that paragraph 46 of the Guidance Note seems to suggest that shares purchased by ESOPT from the market should be excluded in calculating the weighted average number of outstanding shares for purposes of basic EPS calculation, whereas, for purposes of diluted EPS computation, such shares would be considered as potential equity shares. In fact, Illustration 3 of Appendix VII to the Guidance Note clearly explains that when shares are purchased by the Trust from market, such shares represent the shares that have already been issued by the enterprise and the same should continue to be included in the shares outstanding for the purpose of calculating basic EPS as would have been done prior to the purchase of the shares by the Trust. Since the exercise of stock options granted under the plan does not result into any fresh issue of shares, the stock options granted would not be considered as potential equity shares for the purpose of calculating diluted EPS. 22. As regards the issue on audit under section 44AB of the Income-tax, 1961 (tax audit), the Committee notes section 115JB (2) of the Income-tax Act, 1961, as reproduced in paragraph 14 above and is of the view that in the case of listed companies, the financial statements prepared for statutory audit are relevant for tax audit also, subject to the following:
D. Opinion 23. On the basis of the above, the Committee is of the following opinion on the issues raised by the querist in paragraph 17 above:
________ [1]Opinion finalised by the Committee on 5.4.2013 and 6.4.2013. [2]Acquisition of own shares of a company by employee welfare trusts (including ESOS/ESPS) from secondary market is no longer possible in view of the SEBI’s Circular No. CIR/CFD/DIL/3/2013 dated January 17, 2013 which has amended ‘SEBI Guidelines’ and ‘Equity Listing Agreement’. [3]There are further amendments to MAT provisions quoted by the querist |